HomeFENC • NASDAQ
add
Fennec Pharmaceuticals Inc
Previous close
$9.03
Day range
$8.65 - $9.13
Year range
$3.96 - $9.42
Market cap
243.81M USD
Avg Volume
61.89K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 9.65M | 32.91% |
Operating expense | 11.42M | -2.36% |
Net income | -3.15M | 43.24% |
Net profit margin | -32.66 | 57.29% |
Earnings per share | -0.16 | 21.18% |
EBITDA | -2.71M | 46.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 18.70M | -56.55% |
Total assets | 44.88M | -28.95% |
Total liabilities | 52.34M | -18.88% |
Total equity | -7.46M | — |
Shares outstanding | 27.83M | — |
Price to book | -33.44 | — |
Return on assets | -14.96% | — |
Return on capital | -53.84% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -3.15M | 43.24% |
Cash from operations | -3.69M | 56.05% |
Cash from investing | — | — |
Cash from financing | -284.00K | -210.51% |
Net change in cash | -3.97M | 51.17% |
Free cash flow | -2.30M | 67.39% |
About
Founded
1996
Headquarters
Website
Employees
32
